The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
My research focuses on allergies and chronic respiratory disease in children, teenagers and adults. My goal is to identify the factors, which cause these conditions and also the factors, which can stop these conditions from getting worse. I will work with health professionals and the community to make sure the results of my research are used by doctors to improve the care of people with allergies and chronic respiratory diseases.
What Are The Lifetime Clinical Predictors And Risk Factors For Multiple Phenotypes Of Adult Asthma, COPD And Sleep Disordered Breathing? Following Up The TAHS Cohort From 1st To 6th Decade
Funder
National Health and Medical Research Council
Funding Amount
$1,950,689.00
Summary
Breathing gets impaired and impact on the productivity and quality of life when chronic respiratory diseases rise with ageing. Adult chronic respiratory diseases are major causes of illness and death but there are still many gaps in knowledge on how best to prevent and manage these diseases. The proposed program will provide evidence to guide health policy and clinical management of these diseases. These original findings will be of great importance both nationally and internationally.
Allergies and chronic respiratory diseases are major causes of illness and death in Australia. Worryingly there are still many gaps in knowledge on how best to prevent and manage these diseases. The proposed program will investigate these questions and provide evidence to guide health policy and clinical management. As this program is built on state-of the-art methods and technology, these original Australian findings will be of great importance internationally.
Genetic Epidemiology Of Chronic Respiratory Diseases From Childhood To Adulthood: A Prospective Study Of Sibships
Funder
National Health and Medical Research Council
Funding Amount
$889,220.00
Summary
Chronic Respiratory Diseases (CRDs) are a major public health problem. It is known that CRDs change over time but we have no information on causes of these changes. Some childhood asthmatics continue to have asthma as adults and-or develop Chronic Obstructive Pulmonary Disease (COPD) while others are free of any adult CRD. Some of those who do not have childhood asthma develop asthma and-or COPD as adults while the others remain free of CRDs from childhood to adulthood. To investigate risk facto ....Chronic Respiratory Diseases (CRDs) are a major public health problem. It is known that CRDs change over time but we have no information on causes of these changes. Some childhood asthmatics continue to have asthma as adults and-or develop Chronic Obstructive Pulmonary Disease (COPD) while others are free of any adult CRD. Some of those who do not have childhood asthma develop asthma and-or COPD as adults while the others remain free of CRDs from childhood to adulthood. To investigate risk factors for these changes, following up siblings over time is a powerful tool. As siblings share the childhood environment but not the adult environment, it helps to disentangle childhood environment, adult environment and genetic factors. The Tasmanian Asthma Study (TAS) is amongst worlds' major longitudinal respiratory studies and it is unique because it was conceived as a family study, with all the family members and the family environment being surveyed. TAS commenced in 1968 by investigating 8,585 school children born in 1961 (referred to as probands), their parents (16,267) and siblings (21,044). By the end of 2006, we will have completed the 37-year follow-up of the TAS probands, which focuses on non-genetic risk factors for middle-age CRDs. This follow-up together with baseline data now provides a unique opportunity for conducting a sibling study, which can concurrently examine genes, childhood environment and adult environment for change in CRDs. Also, it will provide a platform for future studies to investigate the progression of CRDs in this family cohort. Therefore, we now seek funding to extend the current follow-up to include the siblings. This will be the world's only population-based respiratory sibling study that spans childhood to adulthood. This will provide information for preventing chronic respiratory morbidity and disability in the future, which will be original and significant not only in Australia but also internationally.Read moreRead less
InterLACE: International Collaboration For A Life Course Approach To Reproductive Health And Chronic Disease Events
Funder
National Health and Medical Research Council
Funding Amount
$495,965.00
Summary
Cardiovascular disease and diabetes are major chronic diseases among women. This world-leading research combines data from 7 international and 3 Australian studies of womenÍs health. We will investigate the relationship of reproductive health, from menarche to menopause, with the risk of Type 2 diabetes and cardiovascular disease in later life. Findings will support the development of policies and preventive health strategies to reduce the risk of these chronic diseases.
MULTICENTRE BRONCHIECTASIS STUDY: A Collaborative And International Study Of Bronchiectasis In Indigenous Children.
Funder
National Health and Medical Research Council
Funding Amount
$1,496,414.00
Summary
Aboriginal children have repeated pneumonia episodes; some get better while others develop bronchiectasis (a chronic lung disease). The risk factors associated with progression to bronchiectasis, and the natural history of bronchiectasis in this population is little known. Given the similarities of these diseases among indigenous populations of affluent countries and to increase study size, a collaborative and international study of Indigenous children (Aboriginal and Torres Strait Islander, New ....Aboriginal children have repeated pneumonia episodes; some get better while others develop bronchiectasis (a chronic lung disease). The risk factors associated with progression to bronchiectasis, and the natural history of bronchiectasis in this population is little known. Given the similarities of these diseases among indigenous populations of affluent countries and to increase study size, a collaborative and international study of Indigenous children (Aboriginal and Torres Strait Islander, New Zealand Maori or Pacific Islander and Alaskan Native) has been initiated. In Indigenous children, we aim to define the natural history of chronic moist cough (those at risk of developing bronchiectasis) and bronchiectasis, identify the risk factors associated with progression from early-mild disease (chronic moist cough) to bronchiectasis and to define the role of continuous antibiotic treatment in the prevention of recurrent pulmonary infections that are very common in these children. We plan to follow up Aboriginal children aged 12 months to 8 years diagnosed with bronchiectasis or chronic moist cough. For those diagnosed with bronchiectasis, after fully informed consent is obtained from the parent(s), the child will be allocated by chance to one of the 2 treatment regimes: (1) Azithromycin once-week or (2) placebo once-week. Children will receive the medication or the placebo for a period of 24 months. All these children will be clinically seen 2x-year by the study's paediatrician and 2x-year by the research nurse for the duration of the study. By documenting, for the first time, the epidemiology and natural history of children with chronic moist cough and bronchiectasis, the study will provide a much-needed rationale for their management. If we can scientifically show that this is true, that Azithromycin is effective in reducing the number of respiratory infections, this would be an achievable advance in the treatment in the field for these children.Read moreRead less
Chronic Disease Epidemiology In Different Populations: Risk Factors, Detection And Prevention
Funder
National Health and Medical Research Council
Funding Amount
$621,458.00
Summary
To investigate causes, detection and prevention of diabetes, cardiovascular disease, and kidney disease in Aboriginal and international populations, I will maintain a long-term cohort with a 20-year follow-up in Aboriginal people and to analyse several large repeated cross-sectional data collected over 25 years in China. For the next 5 years, I will continue to to provide critical epidemiological evidence for the development of health policies and clinical guidelines related to chronic diseases ....To investigate causes, detection and prevention of diabetes, cardiovascular disease, and kidney disease in Aboriginal and international populations, I will maintain a long-term cohort with a 20-year follow-up in Aboriginal people and to analyse several large repeated cross-sectional data collected over 25 years in China. For the next 5 years, I will continue to to provide critical epidemiological evidence for the development of health policies and clinical guidelines related to chronic diseases in different populations.Read moreRead less
A Case Control Study Of Hypertension In The Setting Of Poverty, Overcrowding And Infection.
Funder
National Health and Medical Research Council
Funding Amount
$603,331.00
Summary
It is unclear why chronic diseases are emerging in regions of significant disadvantage, i.e. where people are not overweight, are physically active and relatively young. We aim to identify factors responsible for the development of high blood pressure in a region where there is overcrowding, poverty, and infection. Low cost strategies to modify risk and educate the community can then be developed to prevent the emergence of these diseases.